In a study conducted at the Ovarian Cancer Research Foundation (OCRF) at Monash
Medical Centre in Melbourne, an antibody detection method developed by Biosceptre
successfully identified 100% of the invasive ovarian carcinomas (malignant cancers of
the ovaries) included in the tissue analysis.
- Forums
- ASX - By Stock
- PTD
- ovarian cancer breakthrough
PTD
unknown
ovarian cancer breakthrough
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)